Power

Sputnik V vaccine’s controversy in Brazil, explained

Manufacturers claim the regulator acted unethically, but Anvisa stresses inconsistencies with the immunizer

Shipment of Sputnik V doses. Photo: Abed Rahim Khatib/Shutterstock
Shipment of Sputnik V doses. Photo: Abed Rahim Khatib/Shutterstock

Brazil recently surpassed the milestone of 400,000 Covid-19 deaths amid widespread community transmission of the coronavirus and a sluggish vaccination campaign. Largely using the Chinese-made CoronaVac vaccine, the country has administered at least one shot to 32 million people — just over 15 percent of the entire population. Cities from 20 of Brazil’s 27 states — including seven state capitals — have stopped vaccination altogether, reporting a lack of supplies. Meanwhile, the Brazilian government ensures it has purchased a total of 500 million shots. However, a huge portion only exists on paper, and delivery estimates are suffering repeated...

Access all of The Brazilian Report
Start your 7-day free trial.
Free trial